Ticker: LIPO

Lipella Pharmaceuticals Inc. (NASDAQ: LIPO) has recently released its quarterly financial results for the period ending March 31, 2025. The company's focus remains on the development of innovative drug formulations aimed at addressing serious medical conditions, primarily through the reformulatio...